We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Aragen Bioscience Licenses Protein Production Technology from Proteonic Biotechnology

News   Sep 10, 2015

 
Aragen Bioscience Licenses Protein Production Technology from Proteonic Biotechnology
 
 
 

RELATED ARTICLES

Strategy Could Help Treat Behavioral Abnormalities Linked to Autism

News

Researchers report in Nature Medicine a potential new treatment strategy for autism spectrum disorder – for which many cases are linked to mutated PTEN. Now, using Pten-deficient mice, researchers discover that a previously unexplored pathway goes “awry” in the brain, and by “rescuing” this pathway, it is possible to reverse behavioral and neurophysiological abnormalities.

READ MORE

Compound Kills Chemotherapy-resistant Cancer Cells

News

Study reports the discovery of a compound that is capable of killing chemotherapy-resistant glioblastoma-initiating cells (GICs), raising hopes of producing drugs capable of eradicating refractory tumors with low toxicity.

READ MORE

Metabolic Dysfunction Could Be a Potential Therapy for Alzheimer’s Disease

News

A team of researchers led by Yale-NUS College has found evidence that metabolic dysfunction is a primary cause of Alzheimer's disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE